Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma

Oncology

Volumn 58, Issue 4, 2000, Pages 293-299

  Okusaka, Takuji ^a   Okada, Shuichi ^a   Ueno, Hideki ^a   Ikeda, Masafumi ^a   Yoshimori, Masayoshi ^a   Shimada, Kazuaki ^a   Yamamoto, Junji ^a   Kosuge, Tomoo ^a   Yamasaki, Susumu ^a   Iwata, Ryoko ^a   Furukawa, Hiroyoshi ^a   Moriyama, Noriyuki ^a   Sakamoto, Michiie ^b   Hirohashi, Setsuo ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Hepatocellular carcinoma; Lipiodol accumulation; Transcatheter arterial embolization; Tumor necrosis; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL; PIRARUBICIN;

ADULT; AGED; ARTERY CATHETER; ARTICLE; ARTIFICIAL EMBOLISM; CANCER REGRESSION; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION FUNCTION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; TUMOR NECROSIS;

EID: 0034071842     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012115     Document Type: Article

References (14)

1. Charnsangavej S, Chuang VP, Wallace S, Soo CS, Bowers T: Transcatheter management of primary carcinoma of the liver. Radiology 1983;147:51-55.
2. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401.
3. Yamada T, Makita F, Takahara K, Saitou S, Satou K, Endou K, Shimoda R, Matsuzaki Y, Matsumoto T, Yuasa K, Takagi H, Yamada S, Mori M: Evaluation of the therapeutic effect of TAE on primary liver cancer. Cancer Chemother Pharmacol 1994;33(suppl):S55-S59.
4. Takayasu K, Moriyama N, Muramatsu Y, Suzuki M, Yamada T, Kishi K, Hasegawa H, Okazaki N: Hepatic arterial embolization for hepatocellular carcinoma: Comparison of CT scans and resected specimens. Radiology 1984; 150:661-665.
5. Nakakuma K, Tashiro S, Hiraoka T, Uemura K, Konno T, Miyauchi Y, Yokoyama I: Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983;52:2193-2200.
6. Jinno K, Moriwaki S, Tanada M, Wada T, Mandai K, Okada Y: Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31(suppl):S7-S12.
7. Imaeda T, Yamawaki Y, Seki M, Goto H, Iinuma G, Kanematsu M, Mochizuki R, Doi H, Saji S, Shimokawa K: Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: Correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol 1993; 16:209-213.
8. Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare: Vital Statistics of Japan 1995 (in Japanese), Tokyo, Ministry of Health and Welfare 1997.
9. Goldstein HM, Wallace S, Anderson JH, Bree RL, Gianturco C: Transcatheter occlusion of abdominal tumors. Radiology 1976;120:539-545.
10. Iwai K, Maeda H, Konno T: Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image. Cancer Res 1984;44:2115-2121.
11. Konno T: Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodol. Eur J Cancer 1992;28: 403-409.
12. Yoshikawa M, Saisho H, Ebara M, Iijima T, Iwama S, Endo F, Kimura M, Shimamura Y, Suzuki Y, Nakano T: A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33(suppl):S149-S152.
13. Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, Mok TS, Yeo W, Liew CT, Leung NW, Tang AM, Johnson PJ: Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 1999;5: 1676-1681.
14. Seto M, Kuriyama K, Kasugai T, Kido S, Sawai Y, Kuroda C, Kodama K, Doi O, Horai T, Ando M: Comparison of computed tomography and pathologic examination for evaluation of response of primary lung cancer to neoadjuvant therapy. J Thorac Imaging 1999;14:69-73.